Most lately, it's been discovered that conolidine and the above mentioned derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in comparable locations as classical opioid receptors, it binds to a big selection of endogenous opioids. Contrary to most opioid receptors, this receptor functions like a scavenger and does not activat